SauliusKazimierasGirniusMD

PubMed

• -class transition from bortezomib-based therapy to IRd is an effective approach in newly diagnosed multiple myeloma.
  Robert M Rifkin, Caitlin L Costello, Ruemu E Birhiray, Suman Kambhampati, Joshua Richter, Rafat Abonour, Hans C Lee, Michael Stokes, Kaili Ren, Dawn Marie Stull, Dasha...> ;Future Oncology. 2024 Jan 1
• 1 citations
  In-class transition (iCT) of proteasome inhibitor-based therapy: a community approach to multiple myeloma management.
  Robert M Rifkin, Saulius K Girnius, Stephen J Noga, Ruemu E Birhiray, Suman Kambhampati, Sudhir Manda, Roger M Lyons, Habte A Yimer, Dasha Cherepanov, Eric Lloyd, Pres...> ;Blood Cancer Journal. 2023 Sep 19
• Autologous hematopoietic cell transplantation for multiple myeloma patients with renal insufficiency: a center for international blood and marrow transplant research a...
  Mahindra, A.,Hari, P.,Fraser, R.,Fei, M.,Huang, J.,Berdeja, J.,Callander, N.,Costa, L.,Diaz, M. A.,Freytes, C.,Gale, R. P.,Girnius, S.,Holmberg, L.,Kharfan-Dabaja, M.,...> ;Bone Marrow Transplant.. 2017 Sep 19
• 8 citations
  A rare case of central nervous system amyloidoma treated with fractionated radiotherapy
  Teresa Meier, J Michael Hazenfield, Saulius Girnius, Matthew C. Hagen, Ronald E. Warnick, Jordan Kharofa> ;Journal of Neurosurgery. 2017 Aug 1
• Hispanics Have the Lowest Stem Cell Transplant Utilization Rate for Autologous Hematopoietic Cell Transplantation for Multiple Myeloma in the United States: A CIBMTR R...
  Luciano J Costa, Saad Z Usmani, Saulius K Girnius, Attaphol Pawarode, David H Vesole, Peter H Wiernik, Jeffrey R Schriber, Kwang Woo Ahn, Yago L Nieto, Tomer M Mark, P...> ;Cancer. 2017 May 05
• A Phase II trial of weekly bortezomib and dexamethasone in veterans with newly diagnosed multiple myeloma not eligible for or who deferred autologous stem cell transpl...
  Girnius, S. K.,Lee, S.,Kambhampati, S.,Rose, M. G.,Mohiuddin, A.,Houranieh, A.,Zimelman, A.,Grady, T.,Mehta, P.,Behler, C.,Hayes, T. G.,Efebera, Y. A.,Prabhala, R. H.,...> ;Br. J. Haematol.. 2015 Jan 13
• New hematologic response criteria predict survival in patients with immunoglobulin light chain amyloidosis treated with high-dose melphalan and autologous stem-cell tr...
  Girnius S, Seldin DC, Cibeira MT, Sanchorawala V> ;J. Clin. Oncol.. 2013-07-20
• High-dose melphalan and autologous stem cell transplantation for AL amyloidosis: recent trends in treatment-related mortality and 1-year survival at a single institution.
  Seldin, D. C., Andrea, N., Berenbaum, I., Berk, J. L., Connors, L., Dember, L. M., Doros, G., Fennessey, S., Finn, K., Girnius, S., Lerner, A., Libbey, C., Meier-Ewert...> ;Amyloid. 2011 Jun
• The changing face of AA amyloidosis: a single center experience.
  Girnius, S., Dember, L., Doros, G., Skinner, M.> ;Amyloid. 2011 Jun
• Long-term outcome of patients with monoclonal Ig deposition disease treated with high-dose melphalan and stem cell transplantation.
  Girnius, S., Seldin, D. C., Quillen, K., Dember, L. M., Segal, A., Sanchorawala, V.> ;Bone Marrow Transplant. 2011 Jan
• Short and long-term outcome of treatment with high-dose melphalan and stem cell transplantation for multiple myeloma-associated AL amyloidosis.
  Girnius, S., Seldin, D. C., Skinner, M., Finn, K. T., Quillen, K., Doros, G., Sanchorawala, V.> ;Ann Hematol. 2010 Jun
• Hepatic response after high-dose melphalan and stem cell transplantation in patients with AL amyloidosis associated liver disease.
  Girnius, S., Seldin, D. C., Skinner, M., Finn, K. T., Quillen, K., Doros, G., Sanchorawala, V.> ;Haematologica. 2009 May 21
• Treatment of refractory radiation-induced hemorrhagic proctitis with hyperbaric oxygen therapy.
  Girnius, S., Cersonsky, N., Gesell, L., Cico, S., Barrett, W.> ;Am J Clin Oncol. 2006 Dec
• Male breast cancer: a gender issue.
  Nahleh, Z., Girnius, S.> ;Nat Clin Pract Oncol. 2006 Aug
• Support of trigeminal sensory neurons by nonneuronal p75 neurotrophin receptors.
  Fan, L., Girnius, S., Oakley, B.> ;Brain Res Dev Brain Res. 2004 May 19
• Join now to see all

Abstracts/Posters

• Genomic Landscape of Sex Disparities in Multiple Myeloma
  Saulius K. Girnius, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Long-Term Proteasome Inhibitor (PI) Therapy in Community Patients (Pts) with Newly Diagnosed Multiple Myeloma (NDMM) Transitioning from Bortezomib (Btz)-Based to Ixazo...
  Saulius K. Girnius, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Primary Plasma Cell Leukemia Outcomes Remain Dismal Despite Novel Agents and Hematopoietic Cell Transplantation
  Saulius K. Girnius, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019